BioAgilytix and 360biolabs
BioAgilytix and 360biolabs deliver a unified global bioanalytical strategy, combining the speed and clinical advantages of early-phase development in Australia with integrated PK, immunogenicity, biomarker, and CMC testing across Europe and the United States. Under harmonized quality systems and shared scientific leadership, we support programs from first-in-human through global late-phase studies.
Global Bioanalysis for Every Phase, Every Modality.
Date, time and room information
Tuesday, May 5, 14:15 - 14:30, room Sydney
Category
Commercial stage company
Title of the presentation
Bridging the Hemispheres: Bioanalysis from Early to late Phase, from Australia to Europe
Speaker information
| Name | Position | Institution |
|---|---|---|
| Angela Luttick | Executive Vice President, Commercial | 360biolabs, a BioAgilytix company |
Host and event manager:
Logistics and marketing partner:
